AT&T Inc. stock gains as analysts reaffirm Buy ratings and highlight telecom healthcare push
Published on 09/16/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AT&T Inc. stock (ISIN US00206R1023) is trading with support from fresh analyst interest, with recent Buy ratings and price targets in the mid-20s USD range as of early September 2026, while investors digest the company’s latest quarterly figures and a new virtual healthcare partnership.
Analysts stick with Buy calls and mid-20s price targets
According to The Globe and Mail summarizing TipRanks data on September 15, 2026, Bernstein analyst Laurent Yoon maintains a Buy rating on AT&T with a price target of USD 25.00, while the shares recently closed at USD 26.06, implying modest downside versus that single target.
The same overview reports that the broader analyst consensus compiled by TipRanks stands at a Moderate Buy with an average price target of USD 29.02 for AT&T, pointing to a potential upside of around 12.6 percent from recent levels, making the stock a candidate for investors looking for income combined with moderate capital appreciation potential.
In addition, Citi has reiterated a Buy rating on AT&T with a price target of USD 28.00, according to the TipRanks-based report, placing its target slightly below the average but still above the current share price, which underlines that major houses see some room for gains if the company delivers on its strategic and financial goals.
Q2 2026 earnings underpin the investment case
AT&T’s latest quarterly figures for the second quarter of 2026 provide the fundamental backdrop for these ratings, with the company reporting Q2 2026 results that drove a 3.5 percent gain in the stock on the day of publication, as highlighted in an earnings recap on Stocktwits News dated August 24, 2026.
As that recap notes, AT&T stock extended gains overnight after closing up 3.5 percent following the Q2 earnings release, while remaining down about 6 percent year to date in 2026, showing that the quarter was strong enough to trigger a short-term relief move but has not yet fully reversed earlier weakness.
For investors, the combination of mid-single-digit share price reaction to Q2 2026 and a year-to-date performance of minus 6 percent creates a mixed picture: the latest results were welcomed by the market, yet the share price still trades below levels seen at the beginning of the year, leaving room for further recovery if subsequent quarters confirm the positive trend.
Telecom pushes into virtual healthcare to deepen customer ties
Beyond traditional telecom metrics, AT&T is also expanding into adjacent services to differentiate its offer. According to an analysis on Simply Wall St from September 15, 2026, AT&T is partnering with LifeMD to offer free virtual healthcare and pharmacy services to eligible wireless and fiber customers in the United States.
The program, as described in that report, covers primary care, urgent care and dermatology telehealth visits and is designed to be available to more than 100 million AT&T subscribers at no additional cost, with LifeMD providing the clinical network and digital platform while AT&T integrates the service into its consumer plans.
This move is strategically significant for AT&T because it aims to increase customer stickiness and perceived value without raising headline plan prices; if the initiative succeeds in reducing churn or supporting premium pricing, it could ultimately feed through to higher revenue and margin stability in upcoming quarters compared with the Q2 2026 baseline.
Market performance and valuation context for AT&T stock
While detailed real-time price data were not highlighted in the latest analyst and news summaries, the reported recent closing level of USD 26.06 on the New York Stock Exchange provides a useful reference for valuation discussions as of mid-September 2026.
Using the average analyst price target of USD 29.02 as reported in the TipRanks compilation, this closing price places AT&T stock roughly 11 to 13 percent below the consensus fair value estimate, suggesting that the market is still pricing in either execution risk or structural challenges in the telecom sector despite the company’s recent efforts to stabilize performance.
The year-to-date decline of about 6 percent in 2026 mentioned in the Q2 earnings recap also indicates that, even after the Q2-related bounce, AT&T stock has lagged a typical income-investor expectation of steady or slightly positive total returns, underscoring the importance of the upcoming quarters and the success of initiatives such as the LifeMD partnership.
Risks and next catalysts to watch
The analyst overview compiled by TipRanks and cited by The Globe and Mail highlights that, despite the Moderate Buy consensus and attractive dividend profile, AT&T still faces sector-wide challenges and company-specific execution risks, which are reflected in the fact that the stock trades below the average analyst target and only modestly above certain individual targets like the USD 25.00 level from Bernstein.
More cautious commentary comes from research firms focusing on earnings revisions: according to a feature on Yahoo Finance dated September 15, 2026, AT&T currently carries a Zacks Rank 3 (Hold), signaling an expectation that the shares may perform broadly in line with the wider market rather than strongly outperform in the near term.
For retail investors, this mix of Buy ratings with higher price targets on one hand and a neutral Zacks Rank on the other underlines that AT&T remains a relatively defensive telecom income play, but not a high-conviction growth story; upcoming earnings and any additional strategic announcements similar to the LifeMD partnership will be key in determining whether the stock closes the gap to the roughly USD 29 consensus target or continues to range around the mid-20s.
AT&T stock price level as of mid-September 2026
As of mid-September 2026, AT&T stock is trading on the New York Stock Exchange at around USD 26.06 per share based on the latest closing level cited in analyst commentary, positioning it below the average price target of USD 29.02 and slightly above individual targets such as Bernstein’s USD 25.00 mark.
AT&T Inc. stock facts
- Company: AT&T Inc.
- ISIN: US00206R1023
- Ticker: T
- Trading venue: NYSE
- Sector / Industry: Communication Services / Integrated Telecommunication Services
- Index membership: S&P 500
